Cytoreductive nephrectomy: questions remain after CARMENA
NATURE REVIEWS UROLOGY(2018)
摘要
Cytoreductive nephrectomy, a standard approach for de novo metastatic renal cell carcinoma in the era of cytokine therapy, has been upheld during the age of targeted therapy on the basis of retrospective data. Now, the first level I prospective data from the CARMENA and SURTIME trials challenge this standard.
更多查看译文
关键词
Renal cancer,Surgery,Medicine/Public Health,general,Urology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要